Posts

The Kissing Defense: Professional Athletes, Drugs and the ‘No Fault/No Significant Fault’ Tests in Arbitration

By Martin Maloney

Arbitration and Reducing a Suspension Under the No Fault/No Significant Fault Tests

In 2014, Major League Baseball (“MLB”) and the MLB Players Association (the “MLBPA”) agreed to a joint drug prevention program aimed at strengthening the detection and enforcement against players’ use of prohibited recreational and performance-enhancing drugs (“PEDs”).[1] As part of the agreement, MLB incorporated a “no fault/no significant fault” tests, whereby an arbitration panel may vacate a player’s mandatory suspension for testing positive to the use of banned substances if the player can demonstrate that “the presence of the Prohibited Substance in his test result was not due to his fault or negligence,” or reduce the length of the suspension if the player can provide “clear and convincing evidence that he bears no significant fault or negligence.”[2] For instance, Raul Mondesi Jr.’s eighty-game suspension for a first time violation of MLB’s drug policy in 2016 was reduced to fifty-games after Mondesi was able to demonstrate that his positive test of a banned substance was inadvertent and the result of taking an over-the-counter cold and flu medicine he had bought while in the Dominican Republic.[3]

Read more